MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

01 Jun 2024 Evaluate
The sales moved up 26.10% to Rs. 373.32 millions for the March 2024 quarter as compared to Rs. 296.06 millions during the year-ago period.Net profit surges 88.07% to Rs. 125.93  millions  from Rs. 66.96 millions in the quarter ended March 2024.Operating Profit saw a handsome growth to 182.55 millions from 89.80 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 373.32 296.06 26.10 1258.95 913.58 37.80 1258.95 913.58 37.80
Other Income 13.24 3.40 289.41 30.67 7.17 327.75 30.67 7.17 327.75
PBIDT 182.55 89.80 103.29 448.77 241.60 85.75 448.77 241.60 85.75
Interest 1.46 0.77 89.61 5.98 1.80 232.22 5.98 1.80 232.22
PBDT 181.09 89.03 103.40 442.79 239.80 84.65 442.79 239.80 84.65
Depreciation 18.57 10.32 79.94 61.10 37.42 63.28 61.10 37.42 63.28
PBT 162.52 78.71 106.48 381.69 202.38 88.60 381.69 202.38 88.60
TAX 36.59 11.75 211.40 100.52 50.53 98.93 100.52 50.53 98.93
Deferred Tax -0.15 -2.33 -93.56 6.74 -2.84 -337.32 6.74 -2.84 -337.32
PAT 125.93 66.96 88.07 281.17 151.85 85.16 281.17 151.85 85.16
Equity 125.83 121.07 3.93 125.83 121.07 3.93 125.83 121.07 3.93
PBIDTM(%) 48.90 30.33 61.21 35.65 26.45 34.79 35.65 26.45 34.79
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..